The ascendancy of Viagra and its effect on the pharmaceutical landscape presents a complex question for traders. While the initial sales figures were remarkable, the patent has ended, leading to a wave of generic alternatives that are eroding earnings. Furthermore, the industry is facing challenges related to aging trends and changing healthcare… Read More